Abstract

e22139Background: We aimed to determine the attitudes of oncologists regarding their discussions about prognosis with patients with incurable cancer. Methods: We conducted an online survey of medic...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Discussion of costs and financial burden in clinical practice: A survey of medical oncologists in Australia.
Martin R Stockler ... Rachael L Morton
PloS one | VOL. 17
Martin R Stockler, et. al.Martin R Stockler ... Rachael L Morton
21 Oct 2022
Communicating prognostic information: what do oncologists think patients with incurable cancer should be told?
Andrew Martin ... Nicola J Lawrence
Internal medicine journal | VOL. 50
Andrew Martin, et. al.Andrew Martin ... Nicola J Lawrence
01 Dec 2020
Managing patients with advanced cancer: the benefits of early referral for palliative care
Ian E Haines
Medical Journal of Australia | VOL. 194
Ian E HainesIan E Haines
01 Feb 2011
Oncologists' and Physiatrists' Attitudes Regarding Rehabilitation for Patients With Advanced Cancer
Gayle R Spill ... Fay J Hlubocky
PM&R | VOL. 4
Gayle R Spill, et. al.Gayle R Spill ... Fay J Hlubocky
01 Feb 2012
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes
Cristina Astrid Tentori ... Fabio Ciceri
Journal of Clinical Oncology | VOL. -
Cristina Astrid Tentori, et. al.Cristina Astrid Tentori ... Fabio Ciceri
09 May 2024
Addressing Disability in Cancer Survivors
Rachelle Brick ... Emily S Tonorezos
Journal of Clinical Oncology | VOL. -
Rachelle Brick, et. al.Rachelle Brick ... Emily S Tonorezos
09 May 2024
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study
Susanna Hegewisch-Becker ... Niall C Tebbutt
Journal of Clinical Oncology | VOL. -
Susanna Hegewisch-Becker, et. al.Susanna Hegewisch-Becker ... Niall C Tebbutt
09 May 2024
A pivotal phase 2 single-arm study of glecirasib (JAB-21822) in patients with NSCLC harboring KRAS G12C mutation.
Yuankai Shi ... Zhengbo Song
Journal of Clinical Oncology | VOL. 42
Yuankai Shi, et. al.Yuankai Shi ... Zhengbo Song
30 Apr 2024
View more papers